MET and colorectal carcinoma: A meta-analysis of 11 retrospective studies (including 1895 patients with CRC) suggested that OS (HR 1.33, 95% CI 1.06–1.59) and PFS duration (HR 1.47, 95% CI 1.03–1.91) in patients with positive c-Met was low (Liu et al., 2015).